Nitazoxanide Pharmacokinetic Parameters in Hepatic Impaired Patients

Pharmacokinetics of Amcenestrant in Female Hepatic Impaired Participants as Compared to Participants With Normal Hepatic Function

NCT05126329 ·Status: TERMINATED ·Phase: PHASE1

A Study to Evaluate the Drug Levels, Safety, and Tolerability of BMS-986036 in Participants With Normal Liver Function and Participants With Moderate and Severe Liver Impairment

NCT04634149 ·Status: COMPLETED ·Phase: PHASE1

Ulonivirine (MK-8507) in Participants With Mild or Moderate Hepatic Impairment (MK-8507-014)

NCT05093972 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

Study to Assess Pharmacokinetics, Safety, and Tolerability of MT-7117 in Subjects With Normal and Impaired Hepatic Function

NCT04116476 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics Study of MCI-186 in Subjects With Mild or Moderate Hepatic Impairment

NCT03289234 ·Status: COMPLETED ·Phase: PHASE1

Open Label Pharmacokinetic Study of SAR302503 in Subjects With Hepatic Impairment

NCT01762462 ·Status: COMPLETED ·Phase: PHASE1

Study to Assess Drug Levels and Safety of Golcadomide (BMS-986369) in Healthy Participants and Participants With Different Degrees of Hepatic Impairment

NCT06535399 ·Status: COMPLETED ·Phase: PHASE1

STUDY OF PF-06882961 IN PARTICIPANTS WITH AND WITHOUT VARYING DEGREES OF HEPATIC IMPAIREMENT

NCT04604496 ·Status: COMPLETED ·Phase: PHASE1

A Single-dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of BMS-986263 in Participants With Varying Degrees of Liver Impairment

NCT04225936 ·Status: COMPLETED ·Phase: PHASE1

Single-dose, Pharmacokinetics of AMG 853 in Healthy Adult Subjects

NCT01124279 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics of Metronidazole Dermal Products

NCT03271983 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Pharmacokinetics and Safety Study of Levornidazole Disodium Phosphate for Injection in Subjects With Renal Impairment and Normal Renal Impairment

NCT07033182 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics of Gepotidacin Tablets in Adults and Adolescents Subjects

NCT04079790 ·Status: COMPLETED ·Phase: PHASE1

A Study to Assess Pharmacokinetics of Preladenant in Participants With Chronic Hepatic Impairment (P06513)

NCT01465412 ·Status: COMPLETED ·Phase: PHASE1

GP681 in Volunteers With Hepatic Impairment Compared With Healthy Volunteers

NCT05814926 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics of IDX719 in Participants With Normal and Impaired Hepatic Function (MK-1894-008)

NCT01919125 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate Pharmacokinetics (PK) and Safety of Oral Mobocertinib in Participants With Moderate or Severe Hepatic Impairment (HI) and Normal Hepatic Function

NCT04056468 ·Status: COMPLETED ·Phase: PHASE1

PK Study of T-817 in Subjects With Hepatic Impairment

NCT02693197 ·Status: COMPLETED ·Phase: PHASE1

Single-Dose Pharmacokinetics of MK-3866 in Participants With Hepatic Impairment (MK-3866-006)

NCT03295266 ·Status: TERMINATED ·Phase: PHASE1

A Study to Evaluate Molnupiravir (MK-4482) in Participants With Moderate Hepatic Impairment (MK-4482-016)

NCT05386589 ·Status: COMPLETED ·Phase: PHASE1

A Study Assessing the Mass Balance, Pharmacokinetics, and Metabolite Profiles of a Single Oral Dose of [14C]INCB099280 in Healthy Male Participants

NCT06309394 ·Status: COMPLETED ·Phase: PHASE1

A Study of Mezigdomide in Healthy Participants and Participants With Hepatic Impairment

NCT05707390 ·Status: COMPLETED ·Phase: PHASE1

INC280 in Healthy Subjects With Impaired Hepatic Function and Subjects With Normal Hepatic Function

NCT02474537 ·Status: COMPLETED ·Phase: PHASE1

Open-label Study to Assess the Pharmacokinetics of NKTR-118 in Patients With Impaired Hepatic Function

NCT01392807 ·Status: COMPLETED ·Phase: PHASE1

Open Label Pharmacokinetic Study of SAR302503 in Subjects With Renal Impairment

NCT01763190 ·Status: COMPLETED ·Phase: PHASE1